2025;2:101452 DOI: Received: August 10, 2025 Accepted: November 19, 2025 Published: December 18, 2025 Academic Editor: Charlotte Steenblock, University Clinic Carl Gustav Carus, Germany Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) and dual incretin agonists have demonstrated significant potential in improving adipose tissue function beyond their established effects on appetite suppression and weight loss
4, nine GSTAs possessed GST N Alpha or Thioredoxin like superfamily and GST C Alpha domain, GSTM2 possessed GST N Mu and GST C Mu domain, GSTT1L and GSTT1 possessed GST N Theta and GST C Theta domain, and GSTO2 possessed GST N Omega and GST C Omega domain, while the other four GSTs possessed special domain
Upon analysis, researchers found that Ozempic-related weight loss in mice resulted in a lean muscle mass decrease of about 10%, which is less than some previous studies report
Pharmaceutical companies make billions from chronic disease treatment, not prevention
2022;21:e12787